News & EventsBusiness UpdatePillar5 Pharma has completed a major $13M+ expansion to our sterile ophthalmic suite. With this increase, we are actively looking for customers to fill this capacity. Part of this investment was the introduction of the first North American facility with multi-dose preservative free (MDPF) capabilities.Preservative free has experienced great growth in Europe and is currently in competition with Blow-Fill Seal. MDPF is more convenient and affordable compared to unit-dose as it has calibrated drops, one drop at a time. MDPF devices have a one-way valve to ensure no contaminated liquid is re-introduced into the container after a drop has been dispensed.Contact our Business Development group to learn more.